...
首页> 外文期刊>Theranostics >Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
【24h】

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging

机译:糖原合酶激酶3(GSK-3)靶向治疗和成像

获取原文

摘要

Glycogen synthase kinase-3 (GSK-3) is associated with various key biological processes, including glucose regulation, apoptosis, protein synthesis, cell signaling, cellular transport, gene transcription, proliferation, and intracellular communication. Accordingly, GSK-3 has been implicated in a wide variety of diseases and specifically targeted for both therapeutic and imaging applications by a large number of academic laboratories and pharmaceutical companies. Here, we review the structure, function, expression levels, and ligand-binding properties of GSK-3 and its connection to various diseases. A selected list of highly potent GSK-3 inhibitors, with IC50 50 <5 μM for non-ATP-competitive inhibitors, were analyzed for structure activity relationships. Furthermore, ubiquitous expression of GSK-3 and its possible impact on therapy and imaging are also highlighted. Finally, a rational perspective and possible route to selective and effective GSK-3 inhibitors is discussed.
机译:糖原合酶激酶3(GSK-3)与各种关键的生物学过程相关,包括葡萄糖调节,细胞凋亡,蛋白质合成,细胞信号传导,细胞转运,基因转录,增殖和细胞内通讯。因此,GSK-3已经涉及多种疾病,并且被许多学术实验室和制药公司专门针对治疗和成像应用。在这里,我们审查GSK-3的结构,功能,表达水平和配体结合特性及其与各种疾病的关系。分析了所选的高效GSK-3抑制剂的清单,这些清单的非ATP竞争性抑制剂的IC 50 50 <5μM,用于结构活性关系。此外,还强调了GSK-3的普遍表达及其对治疗和影像学的可能影响。最后,讨论了选择性和有效的GSK-3抑制剂的合理观点和可能途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号